PTAB Nixes Patent For Valeant's Antifungal Jublia
The Patent Trial and Appeal Board on Wednesday invalidated the entirety of a Kaken Pharmaceutical Co. patent used to create Valeant Pharmaceuticals International Inc.'s antifungal medication Jublia, finding that it had...To view the full article, register now.
Already a subscriber? Click here to view full article